Sreedevi Gondi, MD
Interventional Cardiology · Louisville, KYNPI 1811186760
Payments from drug & device makers
Across 551 payments — averaging $970.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$437K
- Inari Medical, Inc.$75K
- Abbott$21K
- Pfizer$433
- Novartis$292
- Boston Scientific$192
- plus $1K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 335 | $436,653 |
| Inari Medical, Inc. | 63 | $74,686 |
| Abbott | 44 | $21,314 |
| Pfizer | 27 | $433 |
| Novartis | 17 | $292 |
| Boston Scientific | 4 | $192 |
| Penumbra, Inc. | 1 | $150 |
| Asahi Intecc USA, Inc. | 2 | $142 |
| E.r. Squibb & Sons, L.L.C. | 10 | $137 |
| AstraZeneca | 9 | $127 |
| Johnson & Johnson | 7 | $103 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $78 |
| Astellas Pharma US Inc | 5 | $68 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Abiomed | 1 | $49 |
| Regeneron Healthcare Solutions, Inc. | 3 | $46 |
| Vital Connect, Inc | 2 | $44 |
| Terumo Medical Corporation | 1 | $43 |
| Boehringer Ingelheim | 2 | $34 |
| Lexicon Pharmaceuticals, Inc. | 2 | $31 |
| Novo Nordisk | 2 | $30 |
| Amgen | 2 | $24 |
| Teleflex LLC | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Atricure, Inc. | 1 | $15 |
How this compares
$534,812 in reported general payments places this provider in the 95th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Louisville
- Thomas TuLouisville$1.4M
- Naresh SolankhiLouisville$545K
- Daniel StewartLouisville$290K
- Daniel RothschildLouisville$203K
- Ravi SharmaLouisville$109K
- Christopher SemderLouisville$103K
- Abdullahi OseniLouisville$97K
- Michael FlahertyLouisville$87K
- Sadip PantLouisville$45K
- Prafull RahejaLouisville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.